Candel Therapeutics Inc (CADL) valuation · rev $125.0K
Candel Therapeutics Inc (CADL) rev $125.0K.
| Metric | Value |
|---|---|
| Market cap | $592.0M |
| Revenue | $125.0K |
| P/S | 4736.2 |
| P/B | 4.2 |
CADL valuation FAQ
What is CADL's market cap?
Candel Therapeutics Inc (CADL) market cap is $592.0M on the latest cached fundamentals snapshot.
What is CADL's latest revenue?
Latest cached Candel Therapeutics Inc (CADL) revenue was $125.0K. Statements: https://lician.com/financials/cadl
What is CADL's price-to-sales ratio?
Candel Therapeutics Inc (CADL) price-to-sales (P/S) is 4736.2, cached market cap $592.0M divided by revenue $125.0K.
What is CADL's price-to-book ratio?
Candel Therapeutics Inc (CADL) price-to-book (P/B) is 4.2 on the latest cached fundamentals snapshot.
How many CADL valuation scalars are listed on this page?
This page lists 4 cached valuation scalars for Candel Therapeutics Inc (CADL): Market cap, Revenue, P/S, and P/B.
Where is CADL valuation listed?
Cached valuation multiples for Candel Therapeutics Inc (CADL) are listed at https://lician.com/valuation/cadl.
Not investment advice. Cached rows, not a live tape.